SERB is an independent pharmaceutical company involved in the development, marketing and distribution of essential drugs in the fields of Critical Care, Toxicology, Ophthalmology, Endocrinology and Infectious Diseases.

SERB develops its portfolio of niche specialists’ products, through R&D’s partnerships and specific acquisitions, to maintain availability of life-saving medicines and answer unmet medical needs.

Our commitment is to continue to offer essential drugs meeting Public Health needs.